Nabriva Therapeutics LEAP 2 Phase 3 Trial Topline Results Conference Call Monday May 21, 2018 8:30 AM EDT Click here for Webcast Supporting Materials Nabriva Therapeutics LEAP 2 Phase 3 Trial Topline Results Presentation 2.6 MB
